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Abstract
When a boy is diagnosed with an X-linked condition such as Duchenne or Becker muscular dystrophy (D/BMD), the mother
learns not only of her own potential carrier risk but also that of her daughters. Before the daughters are seen in the Genetics Clinic,
responsibility for disclosing carrier risk information falls mainly to their mothers. We know little about if when and how these
daughters are being told about their risk, and how mothers find the experience. Should we be doing more to help and support
them? Using qualitative methods, six mothers known to the Manchester Centre for Genomic Medicine were interviewed about
the disclosure of D/BMD carrier risk information to their daughters. The four key themes that arose are presented: communication
process, facilitators of disclosure, barriers to disclosure and support and information. Despite the participants’ endeavours to be
open and honest with their daughters and their belief that they had fully disclosed, key information was often withheld. Major
barriers to discussion of the future, including reproductive options, were apparent. These were partly overcome by the involve-
ment of genetic counsellors (GCs). The participants suggested a greater involvement of GCs, proactively sending appointments
and written information, and offering carrier testing more flexibly.
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Introduction
Duchenne and Becker muscular dystrophies (DMD and
BMD) are progressive muscle wasting disorders caused by
mutations in the dystrophin gene and inherited in an X-
linked manner, with symptoms usually apparent in early
(DMD) or late (BMD) childhood (Emery 2002). Although a
third of cases occur as de novo mutations in the affected male,
the majority are inherited from a carrier mother (Haldane
1935). Therefore, a new diagnosis often coincides with the
mother learning of her own potential carrier status and that
of her daughters. Whilst female carriers are usually asymp-
tomatic, 5–10% do manifest symptoms, which can include
muscle weakness and cardiomyopathy (Grain et al. 2001;
Politano et al. 1996; Van Westrum et al. 2011).
The decision about whether and when to undergo carrier
testing can be complex and emotional, especially as the results
can have major reproductive implications (Lewis et al. 2011).
Kay and Kingston (2002) interviewed carriers of ‘serious’ X-
linked conditions including nine DMD carriers and found that
almost all intended to make reproductive decisions to avoid
having an affected child. This highlights the importance of at-
risk females knowing about their potential carrier status, ge-
netic testing and reproductive options before starting a family,
to enable them to make informed reproductive choices.
However, due to the young onset of DMD and BMD, female
siblings are often children themselves when the diagnosis in
their family is made and their potential carrier risk is realised,
so the initial responsibility for disclosing this information to
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the child falls mainly to the parents. Few studies have ex-
plored the communication of X-linked carrier risk information
to at-risk daughters, so we know little about if when and how
they are being told about their risk, and how families find the
experience (Plumridge et al. 2010; Wilson et al. 2004).
In general, it is known that disclosure of genetic risk infor-
mation to children is undertaken almost exclusively by
mothers outside of the Genetics Clinic and tends to be a pro-
cess rather than a single event (Forrest Keenan et al. 2009;
McConkie-Rosell et al. 2009; Metcalfe et al. 2011, 2008;
Rowland and Metcalfe 2013). Children who receive genetic
risk information gradually and appropriately from a young age
tend to find it less shocking and are able to cope and adapt to
the information well by assimilating it into their self-identity
as they grow up (Metcalfe et al. 2011, 2008; Plumridge et al.
2011). Following a meta-thematic synthesis of research into
family communication of genetic risk information, Rowland
and Metcalfe (2013) recommended that parents should dis-
close genetic risk information in an open and honest manner,
at developmentally appropriate stages, gradually, throughout
childhood and adolescence, whilst acknowledging and ad-
dressing their child’s emotions. Establishing an open and hon-
est dialogue between the parent and child at an early stage
makes it more likely the child will feel confident to approach
their parent when questions arise, rather than them indepen-
dently accessing potentially less accurate and worrying
sources (Metcalfe et al. 2011, 2008; Plumridge et al. 2011).
Whilst effective disclosure of genetic risk information can
lead to a stronger and more resilient family unit, limited dis-
closure can damage family relationships (Fanos and Puck
2001; Metcalfe et al. 2008, 2011; Plumridge et al. 2011).
Plumridge et al. (2011) examined parental communication
with siblings of children affected by one of six genetic condi-
tions, inherited in various ways (including DMD), and found
that conversations tended to focus around the health implica-
tions rather than the genetic risk. Disclosure of genetic risk
information to children is a daunting task for many parents,
who report feeling unsupported and ill-equipped (Metcalfe
et al. 2008, 2011; Rowland and Metcalfe 2013). Parents often
feel conflicted, weighing the need to provide valuable genetic
information against the desire to protect their child from po-
tential harm (Gaff et al. 2007). Stress, guilt and fear are prom-
inent emotions and contribute to delayed, avoided or incom-
plete disclosure (Forrest Keenan et al. 2009; Metcalfe et al.
2011; Plumridge et al. 2011). Parents also deliberate over the
optimal time for disclosure, concerned that they may harm
their child by telling them information too early or too late,
so they will often wait for their child to ask questions, which
can result in delayed disclosure (Etchegary and Fowler 2008;
Forrest Keenan et al. 2009; Metcalfe et al. 2008, 2011).
Plumridge et al. (2010) recognised that mothers fromDMD
families found talking to their children particularly difficult,
often avoiding cues and leaving out important information,
such as the inheritance pattern or the ‘Duchenne’ descriptor
to prevent the children from finding out more information
independently. As a result, the daughters in their cohort rarely
understood about their carrier risk or testing options before
age 16, which was later than for the other conditions they
studied. They proposed that this might be due to the progres-
sive and life-limiting nature of DMD being more difficult to
discuss, or the high level of care required by the mothers being
prioritised over providing information to their children. They
also propose that the X-linked inheritance pattern leads to
increased maternal guilt, impacting on their ability as the main
communicator.
Although children and their parents tend to agree that the
initial disclosure should be by the parents, who know the child
best, they felt that this should be with the support and advice
of health professionals (Forrest et al. 2008; McConkie-Rosell
et al. 2009; Metcalfe et al. 2008; 2011; Plumridge et al. 2010,
2011). An international workshop on ‘Facilitating family ad-
justment to a diagnosis of Duchenne muscular dystrophy’
recommended that health care professionals should proactive-
ly encourage parents to discuss the condition with their chil-
dren and ensure they are available to provide help and guid-
ance for parents during the process (Poysky and Kinnett
2009). Rowland and Metcalfe (2013) concluded that a greater
support is required from health professionals in order to facil-
itate family communication about genetic risk. They proposed
using genetic counselling sessions to explore family commu-
nication patterns, suggest techniques and provide resources to
assist parents in disclosing genetic risk information to their
children.
In order to provide the required support, we must first un-
derstand more about this communication process. This study
explores mothers’ experiences of communicating carrier risk
information to daughters at risk of DMD or BMD.
Methods
For this qualitative study, semi-structured telephone inter-
views were used to understand ‘What is the process of family1
communication of genetic carrier risk information from
mothers to daughters (aged 12–18 years) who are potential
carriers of DMD and BMD?’ The objectives were to explore:
1. The preparation for and communication of a DMD/BMD
carrier risk to daughters aged 12–18 years
2. The perceived facilitators and barriers to the disclosure of
this information
3. Support or information that was or would be helpful
1
The term ‘family’ is used to describe parents and their children.
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Participants
Purposive sampling was used to identify eligible participants:
mothers with at least one daughter aged 12–18 years at the
time of interview at risk of being a carrier, from a register of
DMD and BMD families known to the Manchester Centre for
Genomic Medicine. The mothers must have been aware of
their own carrier status for at least 6 months prior to the inter-
view to allow time for them to adjust to their own potential
genetic status. Osborn and Smith (2008) recommend that five
or six participants are a sufficient sample size—small enough
to allow for a comprehensive analysis of each interview, but
large enough to allow any similarities, differences, conver-
gences and divergences to be examined. To account for the
anticipated attrition, a total of 15 eligible participants were
invited to participate.
Procedures
An information pack was sent to the 15 eligible participants,
inviting them to return a consent form if they wished to par-
ticipate, with the choice of a face-to-face or telephone inter-
view at a mutually convenient time. Interviews were semi-
structured and comprised open-ended questions and prompts.
The interviewer used a flexible topic guide (see
Supplementary File) informed by the literature and developed
with a research advisory group.2 Each interview was tran-
scribed verbatim. The findings of the study were fed back to
the participants as a summary leaflet.
Data Analysis
An inductive thematic analysis was conducted to identify key
themes that emerged around communication of genetic risk
information from the interview data collected (Braun and
Clarke 2006). From the transcripts, key quotes were highlight-
ed and initial codes and observations noted down. Sub-themes
that captured the meaning of a group of codes were ascribed.
The researcher then analysed across the six data sets to cluster
together related sub-themes. Each transcript was colour-coded
to allow quotes, codes and sub-themes to be tracked back to
the original data. Connections were made between the themes,
allowing major themes to emerge (Miles and Huberman
1994).
Results
Six participants took part (Table 1) and all requested telephone
interviews. Four families were affected by DMD and two
were affected by BMD. Five of the mothers were genetically
confirmed carriers with an affected son aged between 10 and
23 years. Only one had a prior family history of the condition
with a maternal uncle affected. One participant’s husband was
affected by BMD, meaning her two daughters were obligate
carriers. The participants had a total of nine daughters between
them, aged 5–18 years old. Of these, four were untested and at
50% risk of being a carrier, two were obligate carriers, two had
been tested (at age 4 and 15) and were carriers and one had
been tested and was not a carrier (at age 14) (Table 1). The
interviews were audio-recorded and lasted between 30 and
45 min. Of the nine non-participants, one declined to take part
citing they were ‘too busy’ and eight did not respond.
Four major themes arose: communication process, facilita-
tors of disclosure, barriers to disclosure and support and
information.
Communication Process
The mothers felt that it was their responsibility to disclose
carrier risk information to their daughters and had asserted
the role of key information provider and gatekeeper of genetic
information. They believed that it was better for them to be
2
The research advisory group consisted of a consultant genetic counsellor, a
professor of health care research and a lay mother of a daughter aged 16 years.
Table 1 Participant details
Participant pseudonym DMD/BMD family Carrier mother? Affected family member
(age of son)
Age of daughter(s)
(years)
Carrier risk? (age at carrier test)
Alicia DMD Yes Son (21 years) 13 50%
Belinda DMD Yes Son (10 years) 13
9
50%
50%
Claire DMD Yes Son (10 years) 12
5
Carrier (4 years)
50%
Deborah DMD Yes Son (20 years) 16 Non-carrier (14 years)
Eleanor BMD Yes Son (23 years) and uncle 18 Carrier (15 years)
Fiona BMD No Husband 18
14
Obligate carrier
Obligate carrier
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their daughters’ main source of information rather than their
daughters seeking information from other sources, and felt
that there was very little dialogue between their daughter
and other family members, such as their father or siblings.
It was evident from all the mothers that disclosure of carrier
risk information was a process that took place over many
years to allow their daughters to assimilate the information
and prepare for the possibility of being a carrier. Six levels
of disclosure were identified as follows (Fig. 1):
The majority of mothers had allowed their daughter to
make an autonomous decision about carrier testing once they
were aware of their risk. However, Claire had insisted that her
eldest daughter was carrier-tested as an infant, soon after her
son was diagnosed. Her daughter was tested and found to be a
carrier at age 4. Interestingly, Claire had found disclosure of
any carrier-related information significantly more difficult
than the other mothers and had not informed either of her
daughters about the genetics or inheritance of DMD/BMD:
It’s something that I do need to discuss at some point in
the near future, but I don’t know, there always seems to
be a lot going on, and I haven’t got to that yet – Claire
She had not disclosed her eldest daughter’s known pos-
itive carrier status to her at the time of interview (aged
12) and planned to disclose it ‘by the time she is in a
serious relationship’. The planned timing of disclosures
emerged as an important factor, with certain milestones
repeatedly mentioned, for example when ‘moving to
high school’, at ‘16 years old’ or when in ‘a serious
relationship’. Sometimes these aided disclosure, but oth-
er times these delayed it:
When she’s 16 if she wants to have blood tests then, you
know, I will go into a bit more depth with her then. I
mean I feel like I could talk to her now about it but I
don’t see much point – Alicia
However, for those who had disclosed more information, the
timings had often been unplanned, with conversations
prompted by their daughters’ questions or sons’ hospital
appointments.
Facilitators of Disclosure
Many participants cited their perceived ‘open and honest’
communication style in addition to remaining ‘positive’ as
facilitators of the disclosure process. They felt that this was
the optimum style of communication, and that if done from a
young age, it would prevent a possible adverse reaction upon
discovery of their risk information:
Levels of Disclosure
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Alicia 13y Untested
Belinda 13y Untested
9y Untested
Claire 12y Yes (tested 
at age 4)
5y Untested
Deborah 16y No (tested at 
age 14)
Eleanor 18y Yes (tested 
at age 15)
Fiona 18y Yes
(obligate) 
14y Yes
(obligate) 
*Disclosure of carrier risk accompanied by reproductive risk and the option of carrier testing
** Reproductive options discussed by the Genetic Counsellor (not the mother) during the clinic appointment
Fig. 1 The six levels of carrier
risk disclosure, demonstrating the
partial disclosure at the time of
interview (see Table 2 for
descriptions of each level of
disclosure)
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I’ve been honest with them from the word go. I won’t
keep things from them because I don’t want them getting
to a certain age and then saying, ‘What? You didn’t tell
me that!’so I’ve been very open with all three children –
Eleanor
However, despite the mothers claiming to have been open and
honest, most had withheld important details (Fig. 1) and were
unsure how much detail to go into with their daughters:
I’m not sure whether to go into the full depth of it, you
know, that it could reduce their lives? – Alicia
For the three daughters who had attended genetic counsel-
ling appointments, the mothers felt that this had improved
their daughters’ understanding and knowledge of the carrier
risk information and their reproductive options. Genetic
counselling was highlighted as a way of overcoming the lim-
itations of the mother’s medical knowledge, and it also tended
to prompt further discussion and questions with the mother
outside of the clinic:
[My first daughter] seemed to want to know more what
would happen in circumstances if she was having a ba-
by, what would happen - which obviously me and her
Dad couldn’t answer.… So [the Genetic Counsellor]
probably explained it more in detail to her medically
more than me. Then she’d come back and was having
a chat with us all and things about it – Fiona
Barriers to Disclosure
The mothers unanimously felt that a lack of knowledge
around the advances in genetic reproductive options had
inhibited them from discussing this with their daughters.
They were aware that reproductive techniques had progressed
since they were last seen, but were unsure what the current
options were for their daughters:
Obviously I’ve tried to prepare them myself as much as I
can, But then there’s other things like IVF and things like
Table 2 Description of the six
levels of carrier risk disclosure Level of disclosure Description
1. Condition Initial discussions about D/BMD usually started from a young
age and were often prompted by their daughters’ questions
regarding their brother’s symptoms or hospital appoint-
ments. The mothers tended to use gentle language such as
‘poorly legs’ or ‘muscles not working properly’.
2. Genetics The fact that D/BMD is an inherited genetic condition usually
came a few years later. The mothers reported that they had
instigated this conversation themselves and some had used
diagrams to aid their explanations.
3. Carrier risk accompanied by reproductive
risk and the option of carrier testing
Five of the six mothers stated they had disclosed their
daughters’ carrier risk at an average age of 10 years old.
They had used figures to represent risk, such as ‘it’s 50/50,
we don’t know which’. During the same conversation, they
informed their daughters that carrier testing would be
available as a blood test when they were older. They had also
disclosed the potential reproductive risk but had not gone
into further detail about reproductive options.
4. Carrier test request Deborah’s and Eleanor’s daughters subsequently requested
carrier testing at age 12 and showed frustration at being told
by their mothers that they could not be tested until they were
age 16. Fiona’s daughters also requested genetic
confirmation of their carrier status at around age 14.
5. Reproductive options and carrier testing Deborah’s daughter, Eleanor’s daughter and Fiona’s eldest
daughter were seen in the Genetics Clinic between ages 14
and 16, following their mothers’ request for an appointment.
Their genetic counsellor discussed the reproductive options
for the first time during their appointment, and carrier testing
was performed in all three cases.
6. Life expectancy Only one mother, Deborah, had discussed the reduced life
expectancy with her son and daughter, as they had been
aware of this since early childhood having been part of a
family support group where many families had lost sons.
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that, like new scientific things, and I’m not too clever on
things like that – Belinda
Two participants stated that they did not plan to discuss their
daughters’ reproductive options ‘until she’s 16’ or ‘after she’s
been tested, only if she’s positive’.
Concern for the future was one of the most significant
inhibitors of disclosure and caused the mothers a great deal
of anxiety. The reduced life expectancy associated with the
condition proved extremely difficult for the mothers to accept,
let alone to discuss with their daughters. They tended to
completely avoid this topic as they were unsure how to best
talk about it:
I haven't actually asked to be honest because I don't
want to upset her, whether she actually knows the full
extent. I mean she knows he is going to get worse but I'm
not sure beyond that… I’m not sure whether to go into
the full depth of it, you know, that it could reduce their
lives – Alicia
Attempting to positively reframe this difficult information
seemed to help the mothers cope, and two mothers repeatedly
mentioned their faith in finding a cure. They had used this to
try and lessen the impact of the information on their daughter,
but in fact, this had led to them evading disclosure:
She doesn’t know that it’s a terminal condition. I’ve kind
of ‘prettied it up’ a bit. A lot of the time I’ve just said,
‘You know the way science is going forward and with
everything that we do’ … I’ve said like, ‘Yes it’s a possi-
bility, we can all die young.’ But I’ve pretty much said
like that’s not going to happen – Claire
The participants also struggled with concern around their
daughters’ reproductive future and reported these conversa-
tions as some of the most difficult. They felt a great deal of
fear and worry about their daughters having to make repro-
ductive choices in the future:
As it stands now I think what’s hardest is looking too far
into the future and… well, thinking negatively really
about her. I’m dreading her having a child, and I am
very worried about the future for [my daughter] really –
Alicia
Support and Information
There was a consensus from the mothers that there was a lack
of professional advice and emotional support available to
them and their daughters:
We never really had any psychological support, or ad-
vice, or anything like that – Alicia
Five of the participants were unsure about how to access sup-
port or advice about carrier risk disclosure, and none of them
had sought or received advice from a genetic counsellor about
communicating carrier risk information to their daughters.
Only Fiona, whose daughter had recently been for a genetic
counselling appointment, was aware that she could re-contact
her genetic counsellor for advice and support but added that
she ‘wouldn’t necessarily have known straight away who to
speak to or who to go to for help’.
Participants suggested sending written information to
mothers once they have had some time for their son’s diagno-
sis to settle in and can begin to think about the implications for
their daughters, including a reminder of the basic facts, a sum-
mary of the reproductive options and advice for communicat-
ing with their daughters. They also stated a need for more
psychological support for their daughters:
Psychological support would have helped a lot. Just to
deal with it with a little bit of support from elsewhere
would have been nice… just somebody there, especially
during the teenage years. – Alicia
Many also recognised a need for additional psychological
support themselves to overcome the carrier guilt and blame
that they had been experiencing for years:
Out of the whole thing no-one has ever tried to counsel
me or offered anything to check how my wellbeing is
about the fact that I’m a carrier – Claire
Apart from Fiona (who was proactively contacted by the
Genetics Department to offer a genetic counselling appoint-
ment to her daughters at age 16), the other participants thought
the availability of genetics services needed to be made clearer
so they would know that they could involve them proactively
during the disclosure process, not just for carrier testing:
Probably to involve the professionals more, and I might
have let them do it more if they had been available,
rather than me. But it wasn’t available so… They should
have been available more to be involved, whereas it was
left all for me to do… it was just a case of ‘well now it’s
down to you to do it or not’, and there wasn’t really any
support from them at all or any sort of guidance really -
Deborah
Follow up families and check how they’re doing, and
just giving them an option of being able to talk. To be
able to just come in for a session to talk about how the
whole thing makes them feel… or a leaflet or anything, I
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think just anything to let them know that there is help out
there, and they’re not just on their own. – Claire
Some participants thought it would be best for the Genetics
Department to re-contact them when their daughters were
‘around 12 years old’; others thought ‘before 16 years old’.
The majority of participants bought up the ‘minimum age
for carrier testing’ as an issue for carrier risk disclosure. They
were under the impression that their daughters ‘could not have
carrier testing until age 16’, so they felt it was unfair to tell
their daughters about their risk at younger ages if they could
not have genetic testing until they reached age 16, because it
would cause them unnecessary worry and anxiety:
Maybe it should be done now, sooner, so we can find out
if they have, or if they haven’t. There’s no point putting
them through all of this and talking to them over the
years about it all and then when they have the test both
of them are fine. It just seemed like a bit of an unneces-
sary… upset – Belinda
They felt that it was important for families to be aware that
earlier carrier testing is an option where appropriate. Although
a couple of the mothers felt that the carrier testing should be
done routinely at birth, the rest thought that the age limit for
carrier testing should just be more flexible. One suggested that
testing should be routinely offered at age of 14, as she felt that
this was preferable to age 16 when they have the additional
pressure of major school examinations and often more volatile
emotions. One participant suggested that girls are often sexu-
ally active before age 16, so she felt it was important that they
know if they are a carrier before then as she felt it would
emphasise the importance of and encourage the use of
contraception.
Discussion
The participants’ experiences show that carrier risk disclosure
is much more complex than simply giving their daughter a
percentage chance of being a carrier. There is a process that
involves the sharing of key pieces of information with their at-
risk daughters at appropriate developmental stages. The infor-
mation needed for the daughters to fully comprehend their
carrier risks were the following: a general understanding about
the condition, its genetics and inheritance; their chance of
being a carrier; and their genetic testing and reproductive op-
tions. The timings of sharing this information varied between
families but the order of information giving was consistent,
not dissimilar from the three-staged model of disclosure of
carrier risk information proposed by McConkie-Rosell et al.
(2011).
Various studies have concluded that potential carriers were
rarely aware of their carrier risk until age 16 (Fanos and Puck
2001;Metcalfe et al. 2011; Plumridge et al. 2010, 2011). Here,
seven of the nine daughters were informed of their carrier risk
at an average age of 10 years old, with conversations about the
condition usually starting at an even younger age than previ-
ously reported by Plumridge et al. (2010).
Although it has previously been suggested that conversa-
tions between parents and children tended to focus on health
implications rather than genetic risk (Plumridge et al. 2011),
for the participants in this study, the converse was found.
Mothers found it easier to discuss genetic risk and inheritance
information than their daughters’ reproductive implications or
the future of their sons’ health. This phenomenon may be
specifically associated with DMD and BMD, possibly as a
consequence of the progressive and life-limiting nature of
the condition, or the X-linked pattern of inheritance.
All participants had endeavoured to be open and honest
with their daughters, but they would often admit having with-
held certain information. Avoidance also seemed to be a prom-
inent issue around disclosure of the life-limiting nature of the
condition. Mothers had recognised their daughters’ need for
information but had often avoided cues or concealed informa-
tion. They thought that genetic counsellors were better placed
to share information on reproductive options, highlighting the
benefits of genetic counsellor involvement with young people.
The general consensus in the literature is that disclosure of
genetic information to children should be by the parents, but
with the support and advice of health professionals (Forrest
et al. 2008; McConkie-Rosell et al. 2009; Metcalfe et al. 2011;
Plumridge et al. 2010; 2011). However, these participants’
experiences suggest that professional support is not being
sought or effectively utilised. A striking observation was that
it had not occurred to the participants to seek advice on carrier
risk disclosure from health care professionals, and all but one
were unaware that they could re-contact the Genetics
Department for support, advice or information regarding this.
Participants felt that a genetic counselling appointment should
be proactively offered to their daughters before age 16, and
that genetic counselling should be promoted as a source of
help and guidance for parents during the disclosure process.
They suggested that genetic counsellors could send out leaf-
lets with information and advice for parents and daughters,
reflecting Rowland and Metcalfe’s (2013) suggestion that a
resource should be developed to include diagrams, disclosure
techniques and examples of appropriate language to use. It
also supports the ‘Recommendations for Health Care
Professionals to support and aid disclosure of genetic infor-
mation’ by Rowland and Metcalfe (2013) to use genetic
counselling sessions with parents to explore, plan and prepare
for disclosure to at-risk children, in a parent-practitioner mod-
el similar to that developed by Sullivan and McConkie-Rosell
(2010). There was also evidence of inconsistency in how
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daughters were followed up by their genetics service and un-
certainty about the age at which they could request carrier
testing.
Helderman-van den Enden et al. (2013) propose testing at-
risk females prenatally for DMD if foetal DNA is available or
postnatally if not, which aligns with the opinions held by two
of the mothers in this study. However, the majority of the
participants favoured their daughters making an informed de-
cision about carrier-testing themselves. Most felt that by age
14, their daughters would have the maturity and understand-
ing necessary to make this decision and cope with the result.
Guidance in the UK around consent in competent minors
states that as long as a young person under age 16 is assessed
to be ‘Gillick competent’, then they have the capacity to con-
sent to genetic testing (Borry et al. 2005; Gillick v West
Norfolk and Wisbech Area Health Authority 1985; Joint
Committee on Medical Genetics 2011; British Society for
Human Genetics 2010). Clearly, further study would be re-
quired to assess the outcomes of D/BMD carrier testing in
young people under age 16.
Study Limitations
This study was conducted in a single National Health Service
(NHS) Genetics Centre in the North West of England, so it is
important to note that other services may have different pro-
tocols for following up affected families and offering contact
or information at certain time points. Therefore, the experi-
ences and recommendations made by these participants may
not be applicable to practice in other centres. This study in-
volved a relatively homogenous sample of mothers in similar
situations, who all believed they were coping well with the
condition as a family and felt that they had ‘done the right
thing’ in communicating with their daughters. Their
experiences may differ from those of mothers who declined
participation or did not feel that they were coping or commu-
nicating well with regard to their daughters’ carrier risks.
Practice Implications
This study supports the case for genetic counsellors to build
long-term relationships with families, rather than limiting
themselves to a single, brief episode of contact. The partici-
pants made a number of suggestions for genetic counsellors
(Table 3). Whilst these may not be wholly applicable to clin-
ical practice in other genetics centres that follow different
protocols in terms of maintaining long-term contact with af-
fected families, it does provide some insight into the model of
service they desire, which may be helpful to consider in the
evaluation and long-term planning of services offered to fam-
ilies affected by D/BMD.
Research Recommendations
It would be beneficial to conduct a longitudinal follow-up
study with these participants, especially those with younger
daughters where the information had not yet been fully
disclosed. It would also be important to consider the views
of the children and young people at risk on when and how
they would like to receive carrier risk information to under-
stand their experience of carrier risk communication, compare
and contrast their experiences and views about disclosure with
that of their mothers and evaluate their support and informa-
tion needs. As family dynamics clearly play an important role,
this may best be achieved through family studies. The views
of the affected sons and fathers could also be explored using a
family approach. It would also be important to include the
opinions of those not keen to participate in formal studies.
Table 3 Participants’ suggestions
for genetic counsellors Suggestion Rationale
More proactive follow-up of families at key stages • To allow genetic counsellors to aid the disclosure
process
• For mothers to feel more supported throughout
• To improve the relationship between the genetic
counsellor and the family
• To make families more aware of the service
Sending written information and advice to the
mothers and daughters when they reach specific
ages
• To provide mothers with up to date information prior
to disclosure to their daughters
Genetic counselling appointment to be proactively
offered to the daughter (at around age 14)
• To aid the disclosure of reproductive information and
options
• To help create time for the daughter to process the
information ahead of deciding about carrier testing
Genetic counselling appointment offered to the
mothers
• To help address the mothers’ own feelings of carrier
guilt and blame
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D/BMD families from other genetics services and countries
should be included in future studies, and it would be interest-
ing to compare practices between different genetics centres to
find out how other genetic counsellors are following up and
supporting these families, and the effect this has on family
communication.
Conclusions
This exploratory study set out to address a gap in the research
by investigating the experiences of mothers responsible for
communicating DMD/BMD carrier risk information to their
at-risk daughters. Carrier risk disclosure was found to be a
process, with a pattern of information giving emerging in a
particular order. All participants had struggled to a greater or
lesser extent with some aspect of the process. The mothers
gave the impression of full disclosure, claiming to have been
completely open and honest with their daughters, but had
often withheld important information leading to partial disclo-
sure. There was a major barrier around discussion of the fu-
ture, specifically discussing reproductive options and the life
limitation of the condition. Genetic counsellors had a role in
overcoming this barrier, by discussing reproductive options
with the daughters at their clinic appointments.
The mothers felt that although they were the right people to
inform their daughters about their chances of being a carrier,
there should be much greater support and advice from genetic
counsellors throughout the process. Their suggestions includ-
ed sending written information and advice about genetic com-
munication with at-risk daughter at certain stages, offering a
genetic counselling appointment to the daughter at around age
14, and making the age limit for carrier testing more flexible.
Further research would be required before any recommenda-
tions could be made for changes to genetic counsellor
practice.
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